DE
56
-2
KEY
53
12
PEP
38
12
FSLR
28
3
ROP
35
-7
EXC
53
3
CHRW
56
-3
IVZ
42
2
ICE
57
-3
VRTX
43
6
EQT
65
11
O
42
-8
L
41
4
AMP
46
3
NDAQ
71
-3
KLAC
57
-5
WMB
62
4
MET
64
3
FCX
49
-4
DD
38
-2
DE
56
-2
KEY
53
12
PEP
38
12
FSLR
28
3
ROP
35
-7
EXC
53
3
CHRW
56
-3
IVZ
42
2
ICE
57
-3
VRTX
43
6
EQT
65
11
O
42
-8
L
41
4
AMP
46
3
NDAQ
71
-3
KLAC
57
-5
WMB
62
4
MET
64
3
FCX
49
-4
DD
38
-2
Financhill
Back

GitLab Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
21

GTLB
GitLab

Last Price:
$40.75
Seasonality Move:
15.68%
Buy
63

HALO
Halozyme Therapeutics

Last Price:
$52.82
Seasonality Move:
5.34%
Sell
21
GitLab (GTLB) is a Sell

Is GitLab a Buy, Sell or Hold?

  • The current GitLab [GTLB] share price is $40.76. The Score for GTLB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • GTLB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Halozyme Therapeutics (HALO) is a Buy

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $52.81. The Score for HALO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • HALO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GTLB Stock Price Chart

What is GitLab's stock price today?

  • The GitLab share price today is $40.76
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GTLB is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $52.81
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GTLB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 32.56 Sell
Chaikin Money Flow: -4209427 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.3 - 49.5) Sell
Bollinger Bands (100): (42.83 - 62.23) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.99 Sell
Relative Strength Index (14 RSI): 41.21 Sell
Chaikin Money Flow: -3919681 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.47 - 55.03) Sell
Bollinger Bands (100): (54.25 - 62.43) Sell

GTLB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.95 Sell
20-day SMA: 45.5 Sell
50-day SMA: 46.23 Sell
200-day SMA: 55.15 Sell
8-day EMA: 42.87 Sell
20-day EMA: 44.93 Sell
50-day EMA: 47.17 Sell
200-day EMA: 52.61 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.64 Sell
20-day SMA: 54.1 Sell
50-day SMA: 56.97 Sell
200-day SMA: 55.96 Sell
8-day EMA: 53.51 Sell
20-day EMA: 54.29 Sell
50-day EMA: 56.08 Sell
200-day EMA: 55.12 Sell

GitLab Earnings Growth & GTLB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.02 per share, an increase this year of $0.50 per share, and an increase next year of $0.12 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.06 per share, an increase this year of $1.19 per share, and an increase next year of $1.27 per share.

GitLab Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):